InfaCare Pharmaceutical
Engaged in the development of pharmaceuticals for the neonatal and pediatric patient population.
Launch date
Employees
Market cap
-
Enterprise valuation
$48—73m (Dealroom.co estimates Jul 2015.)
Upper Merion Township Pennsylvania (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$30.0m | Series A | ||
$28.0m | Series B | ||
| N/A | $3.6m | Series C | |
| N/A | $1.0m | Seed | |
| N/A | $1.3m | Early VC | |
| N/A | $12.1m | Late VC | |
$425m | Acquisition | ||
| Total Funding | $76.0m | ||
Related Content
Recent News about InfaCare Pharmaceutical
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.